Rongchang Pharmaceuticals was founded in 1993 and is headquartered in Yantai, China. It is a modern pharmaceutical enterprise integrating R&D, production, sales, and services, spanning four major sectors: modern traditional Chinese medicine, small molecule and biopharmaceuticals, biopharmaceutical R&D and production services (CDMO), as well as biopharmaceutical company and project incubation.
Rongchang Pharmaceuticals focuses on small-molecule innovative drugs and modern traditional Chinese medicine. With technological innovation as the breakthrough point, the company drives progress through the dual engines of capital and technology, expanding its reach to achieve the strategic goal of benefiting patients worldwide.